Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 58 | Saavedra Jennifer D.Chief Human Resources Officer | Open-market sale | SELL | $13.13M 25.3K sh |
| Sep 9, 2026 traded Sep 4, 2026 |
| 51 | Tiran AssafEVP Cross Suez & Atlantic BU | Open-market sale | SELL | $70K 2,312 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 51 | Tunnell JaneChief Marketing Officer | Open-market sale | SELL | $2.85M 5,436 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 48 | Elimelech ArikEVP HR & Organization | Open-market sale | SELL | $14K 458 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 43 | Cashman SteveChief Business Officer | Open-market sale | SELL | $1.02M 140.1K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 39 | Aquilino BrianChief Operating Officer | Open-market sale | SELL | $313K 6,667 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 38 | Budur KumarCHIEF MEDICAL OFFICER | Open-market sale | SELL | $231K 5,500 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 38 | Mulshine Brendan MartinCo-President and CRO | Open-market sale | SELL | $1.62M 40.0K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 37 | Larson Keith DGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $28.69M 1.89M sh | Sep 9, 2026 traded Sep 9, 2026 |
| 36 | Carlson MeganCAO and SVP, Finance | Open-market sale | SELL | $101K 13.8K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 36 | Collier CharlesPresident, Roku Media | Open-market sale · 10b5-1 plan | SELL | $1.39M 8,843 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 36 | Collier CharlesPresident, Roku Media | Open-market sale · 10b5-1 plan | SELL | $1.39M 8,843 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 35 | Dotan SaarEVP Countries & BD | Open-market sale | SELL | $88K 2,890 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 35 | Lin Elizabeth YeuChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $485K 5,386 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 35 | Budur KumarCHIEF MEDICAL OFFICER | Open-market sale | SELL | $989K 23.0K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 34 | Sluis FrankCFO | Open-market sale | SELL | $19K 687 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 34 | Larson Keith DGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $6.98M 464.2K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 32 | Chin Peter ScottChief Medical Officer | Open-market sale | SELL | $37K 1,654 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 32 | Lin Elizabeth YeuChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $143K 1,590 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 32 | Lindgardt ZhenyaDirector, Chief Executive Officer | Open-market sale | SELL | $40K 20.1K sh | Sep 9, 2026 traded Sep 8, 2026 |
| 32 | Clerc AlexandreSVP, Customers | Open-market sale | SELL | $20K 3,480 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 32 | Dotan SaarEVP Countries & BD | Open-market sale | SELL | $24K 800 sh | Sep 9, 2026 traded Sep 8, 2026 |
| 31 | Lin Elizabeth YeuChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $458K 5,387 sh | Sep 9, 2026 traded Sep 4, 2026 |
| 30 | Phillips DominicSEE REMARKS | Open-market sale · 10b5-1 plan | SELL | $793K 17.9K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 30 | Phillips DominicSEE REMARKS | Open-market sale · 10b5-1 plan | SELL | $518K 11.7K sh | Sep 9, 2026 traded Sep 4, 2026 |
| 48 | Meyer-Gloeckner Birger JohannesDirector | Open-market sale | SELL | $44K 1,531 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 41 | Bradford Tonya WilliamsDirector | Open-market sale | SELL | $64K 1,600 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 36 | Agress Adam LEVP Business Development | Open-market sale | SELL | $2,602 1,112 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 36 | Voorhees Anthony GeneEVP-Admin, CFO, Treasurer | Open-market sale | SELL | $3,283 1,403 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 36 | Courtney Mark RVice President of Supply Chain | Open-market sale | SELL | $1,324 566 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 34 | Lantheus Alpha Therapy, LLC10% Owner | Open-market sale | SELL | $251K 80.8K sh | Sep 8, 2026 traded Sep 3, 2026 |
| 33 | Grayson Blake JeffreyChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $2.10M 30.0K sh | Sep 8, 2026 traded Sep 4, 2026 |
| 32 | Berho Carranza DiegoChief Portfolio Officer | Open-market sale | SELL | $22K 6,219 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 32 | Sever MichalCMO | Open-market sale | SELL | $1,779 34 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 31 | Bernstein HaroldPresident, R&D & CMO | Open-market sale · 10b5-1 plan | SELL | $255K 9,705 sh | Sep 8, 2026 traded Sep 4, 2026 |
| 31 | Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER | Open-market sale | SELL | $249K 5,666 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 31 | Prosor MayaChief Business Officer | Open-market sale | SELL | $57K 1,040 sh | Sep 8, 2026 traded Sep 3, 2026 |
| 52 | Lacerte Rene A.Director, CEO | Open-market sale | SELL | $4.90M 100.9K sh | Sep 4, 2026 traded Sep 2, 2026 |
| 50 | Spetzler David BaxleyPresident | Open-market sale | SELL | $9.73M 393.1K sh | Sep 4, 2026 traded Sep 3, 2026 |
| 48 | Lacerte Rene A.Director, CEO | Open-market sale | SELL | $1.94M 40.4K sh | Sep 4, 2026 traded Sep 2, 2026 |